Literature DB >> 19825110

Toxoplasma and schizophrenia.

R H Yolken1, F B Dickerson, E Fuller Torrey.   

Abstract

Research on infectious agents as a possible cause of schizophrenia has become prominent in the past decade. Toxoplasma gondii has emerged as a prime candidate for a variety of reasons; (i) many studies have reported that individuals with schizophrenia, compared to controls, have a higher prevalence of antibodies to T. gondii, (ii) some individuals with adult toxoplasmosis develop psychotic symptoms similar to those of schizophrenia, (iii) epidemiologically, there are many similarities between toxoplasmosis and schizophrenia, (iv) antipsychotic drugs known to be effective in schizophrenia also inhibit some parasites, including T. gondii, (v) Toxoplasma has been shown to induce elevated levels of dopamine in experimentally infected animals (elevated dopamine is commonly seen in individuals with schizophrenia) and (vi) studies have shown that individuals with schizophrenia, compared to controls, have had greater exposure to cats in childhood. A number of questions remain concerning a role for Toxoplasma in the aetiology of schizophrenia, including the roles of strain variation, the timing and source of infection, and the role of host genes in determining disease susceptibility. The establishment of a firm association between Toxoplasma and the aetiology of schizophrenia and related disorders would represent a major breakthrough in the understanding of these disorders and would lead to novel methods for their treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825110     DOI: 10.1111/j.1365-3024.2009.01131.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  64 in total

1.  Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology.

Authors:  Maria Gulinello; Mariana Acquarone; John H Kim; David C Spray; Helene S Barbosa; Rani Sellers; Herbert B Tanowitz; Louis M Weiss
Journal:  Microbes Infect       Date:  2010-03-27       Impact factor: 2.700

2.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 3.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

4.  Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study.

Authors:  Abhishek Wadhawan; Aline Dagdag; Allyson Duffy; Melanie L Daue; Kathy A Ryan; Lisa A Brenner; John W Stiller; Toni I Pollin; Maureen W Groer; Xuemei Huang; Christopher A Lowry; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-22       Impact factor: 0.581

5.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

Review 6.  Pathogens hijack the epigenome: a new twist on host-pathogen interactions.

Authors:  Natalie C Silmon de Monerri; Kami Kim
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

7.  Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis.

Authors:  Thomas J Whitford; Stephen J Wood; Alison Yung; Luca Cocchi; Gregor Berger; Martha E Shenton; Marek Kubicki; Lisa Phillips; Dennis Velakoulis; Robert H Yolken; Christos Pantelis; Patrick McGorry; G Paul Amminger
Journal:  Schizophr Res       Date:  2012-01-12       Impact factor: 4.939

Review 8.  Toxoplasma gondii infection and behaviour - location, location, location?

Authors:  Glenn A McConkey; Heather L Martin; Greg C Bristow; Joanne P Webster
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

9.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

10.  The correlation between Toxoplasma gondii infection and Parkinson's disease: a case-control study.

Authors:  Mahmoud Mahami Oskouei; Faezeh Hamidi; Mahnaz Talebi; Mehdi Farhoudi; Ali Akbar Taheraghdam; Tohid Kazemi; Homayoun Sadeghi-Bazargani; Esmaeil Fallah
Journal:  J Parasit Dis       Date:  2014-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.